Although patients difficult to treat with oral antidiabetic agents may have been switched to insulin, it is nevertheless noteworthy that a substantial proportion of patients was well controlled on oral agents only, indicating their potential value in the presence of CKD. This evidence concerns the gene INS and chronic kidney disease.